RadNet, Inc. Income (Loss) from Continuing Operations before Income Taxes, Domestic
RadNet, Inc. (RDNT) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $50.37 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-02
- RadNet, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $50.37M, a 17.03% decline from fiscal 2024.
- RadNet, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $60.70M, a 0.55% increase from fiscal 2023.
- RadNet, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $60.37M, a 1.42% increase from fiscal 2022.
- RadNet, Inc. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was $59.53M, a 1.23% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | $50.37M 10-K · filed 2026-03-02 |
| 2024-12-31 | $60.70M 10-K · filed 2026-03-02 |
| 2023-12-31 | $60.37M 10-K · filed 2026-03-02 |
| 2022-12-31 | $59.53M 10-K · filed 2024-02-29 |
| 2021-12-31 | $58.81M 10-K · filed 2024-02-29 |
| 2020-12-31 | -$986.00K 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |